Literature DB >> 31090156

The impact of variations in transcription of DICER and AGO2 on exacerbation of childhood B-cell lineage acute lymphoblastic leukaemia.

Fatemeh Piroozian1, Hoda Bagheri Varkiyani2, Mohsen Koolivand3, Maryam Ansari2, Masoomeh Afsa4, Ali AtashAbParvar5, Kianoosh MalekZadeh1,4.   

Abstract

The expression of microRNA in eukaryotic cells is subject to tightly regulated processing. The altered expression of microRNAs in a number of cancers suggests their contribution to disease pathogenesis, where processing pathways may be involved in disease pathogenesis. In the present study, we evaluated changes in the profile of two main components of microRNA biogenesis, AGO2 and DICER, and assessed their correlation with disease progression in childhood acute lymphoblastic leukaemia (ALL). To achieve this aim, 25 patients afflicted with ALL were included in the study along with 25 healthy subjects as control. The expression level of AGO2 and DICER was evaluated by real-time PCR. The results revealed an increase in the expression of DICER and a decrease in AGO2 in patients. The correlation between the alteration levels of these genes with pathologic events was also studied. This increase or decrease proved to be directly correlated with the progression of the disease particularly in L1 to L2. According to the obtained results, it can be deduced that dysregulation in transcription of DICER and AGO2, involved in the formation of mature microRNAs in cytoplasm of ALL cancer cells, is a part of the pathological molecular mechanism implicated in the exacerbation of this malignancy. Therefore, the genes involved in microRNAs biogenesis that have been studied here could be considered as candidate prognostic markers especially in childhood ALL which will help towards a better understanding of the molecular basis of ALL.
© 2019 The Authors. International Journal of Experimental Pathology © 2019 International Journal of Experimental Pathology.

Entities:  

Keywords:  AGO2; DICER; acute lymphoblastic leukaemia; microRNA biogenesis

Mesh:

Substances:

Year:  2019        PMID: 31090156      PMCID: PMC6658907          DOI: 10.1111/iep.12316

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  36 in total

Review 1.  Acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; Mary V Relling; James R Downing
Journal:  N Engl J Med       Date:  2004-04-08       Impact factor: 91.245

Review 2.  Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.

Authors:  Andrea L Kasinski; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2011-11-24       Impact factor: 60.716

3.  Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas.

Authors:  Dionysios J Papachristou; Angeliki Korpetinou; Efstathia Giannopoulou; Anna G Antonacopoulou; Helen Papadaki; Petros Grivas; Chrisoula D Scopa; Haralabos P Kalofonos
Journal:  Virchows Arch       Date:  2011-07-18       Impact factor: 4.064

4.  Down-regulation of dicer expression in ovarian cancer tissues.

Authors:  Georgios Pampalakis; Eleftherios P Diamandis; Dionyssios Katsaros; Georgia Sotiropoulou
Journal:  Clin Biochem       Date:  2009-09-25       Impact factor: 3.281

5.  Dicer, Drosha, and outcomes in patients with ovarian cancer.

Authors:  William M Merritt; Yvonne G Lin; Liz Y Han; Aparna A Kamat; Whitney A Spannuth; Rosemarie Schmandt; Diana Urbauer; Len A Pennacchio; Jan-Fang Cheng; Alpa M Nick; Michael T Deavers; Alexandra Mourad-Zeidan; Hua Wang; Peter Mueller; Marc E Lenburg; Joe W Gray; Samuel Mok; Michael J Birrer; Gabriel Lopez-Berestein; Robert L Coleman; Menashe Bar-Eli; Anil K Sood
Journal:  N Engl J Med       Date:  2008-12-18       Impact factor: 91.245

6.  Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of Dicer expression.

Authors:  S I Chiosea; E L Barnes; S Y Lai; A M Egloff; R L Sargent; J L Hunt; R R Seethala
Journal:  Virchows Arch       Date:  2008-02-01       Impact factor: 4.064

7.  The let-7 target gene mouse lin-41 is a stem cell specific E3 ubiquitin ligase for the miRNA pathway protein Ago2.

Authors:  Agnieszka Rybak; Heiko Fuchs; Kamyar Hadian; Lena Smirnova; Ellery A Wulczyn; Geert Michel; Robert Nitsch; Daniel Krappmann; F Gregory Wulczyn
Journal:  Nat Cell Biol       Date:  2009-11-08       Impact factor: 28.824

Review 8.  Treatment of childhood acute lymphoblastic leukemia.

Authors:  Martin Stanulla; Martin Schrappe
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

9.  microRNAs regulate human embryonic stem cell division.

Authors:  Junlin Qi; Jenn-Yah Yu; Halyna R Shcherbata; Julie Mathieu; Amy Jia Wang; Sudeshna Seal; Wenyu Zhou; Bradford M Stadler; David Bourgin; Linlin Wang; Angel Nelson; Carol Ware; Christopher Raymond; Lee P Lim; Jill Magnus; Irena Ivanovska; Robert Diaz; Alexey Ball; Michele A Cleary; Hannele Ruohola-Baker
Journal:  Cell Cycle       Date:  2009-11-10       Impact factor: 4.534

Review 10.  The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy.

Authors:  Chengxin Luan; Zixue Yang; Baoan Chen
Journal:  Onco Targets Ther       Date:  2015-10-13       Impact factor: 4.147

View more
  6 in total

1.  The impact of variations in transcription of DICER and AGO2 on exacerbation of childhood B-cell lineage acute lymphoblastic leukaemia.

Authors:  Fatemeh Piroozian; Hoda Bagheri Varkiyani; Mohsen Koolivand; Maryam Ansari; Masoomeh Afsa; Ali AtashAbParvar; Kianoosh MalekZadeh
Journal:  Int J Exp Pathol       Date:  2019-05-15       Impact factor: 1.925

Review 2.  From the Argonauts Mythological Sailors to the Argonautes RNA-Silencing Navigators: Their Emerging Roles in Human-Cell Pathologies.

Authors:  Vasiliki I Pantazopoulou; Stella Georgiou; Panos Kakoulidis; Stavroula N Giannakopoulou; Sofia Tseleni; Dimitrios J Stravopodis; Ema Anastasiadou
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

Review 3.  MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside.

Authors:  Margherita Ratti; Andrea Lampis; Michele Ghidini; Massimiliano Salati; Milko B Mirchev; Nicola Valeri; Jens C Hahne
Journal:  Target Oncol       Date:  2020-06       Impact factor: 4.493

Review 4.  MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools.

Authors:  Ioannis Kyriakidis; Konstantinos Kyriakidis; Aspasia Tsezou
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

5.  Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma.

Authors:  Wei Li; Li-Na Gao; Pei-Pei Song; Chong-Ge You
Journal:  Aging (Albany NY)       Date:  2020-02-22       Impact factor: 5.682

Review 6.  Dicing the Disease with Dicer: The Implications of Dicer Ribonuclease in Human Pathologies.

Authors:  Eleni I Theotoki; Vasiliki I Pantazopoulou; Stella Georgiou; Panos Kakoulidis; Vicky Filippa; Dimitrios J Stravopodis; Ema Anastasiadou
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.